Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations
전염병에 대한 화학 예방 실험 설계: COVID-19 연구 등록에 대한 체계적인 검토에서 얻은 통찰력
Review
[키워드] adaptive
adaptive design
Adaptive platform trial
Adults
alignment
Analysis
attack rate
attack rates
Care
Chain Reaction
Chemoprophylaxis
Chloroquine
clinically
collaboration
component
control group
coronavirus
country
COVID-19
COVID-19 vaccines
database
detect
effect size
effective
Efficacy
Efficacy and safety
eligibility
enrolment
Epidemic
Epidemics
epidemiologically
Evidence
evidence of
exit
feasible
feature
focus
followed by
General population
generate
healthcare worker
Healthcare workers
Hydroxychloroquine
implementation
Infection
Infectious disease
Infectious diseases
information
International
IQR
less
Long-term care
Lopinavir
Lopinavir/ritonavir
mechanism
median
median size
novel vaccines
offer
Older
older adult
Older adults
pandemic
patients
polymerase chain reaction
Polymerase chain reaction testing
PrEP
Primary outcome
Prophylaxis
protocol
provided
public health
randomised
Rapid
recruitment
Registered
Repurposed drug
Repurposed drugs
required
Result
review
Ritonavir
robust
safety analysis
SARS-CoV-2
screened
searched
Serological testing
study population
supplementary material
Supporting
systematic review
target population
Trial
trial infrastructure
Trial registration
trials
utility
Vaccine
Vaccines
virus variants
was used
were assessed
widespread
without symptom
[DOI] 10.1186/s13063-021-05323-4 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s13063-021-05323-4 PMC 바로가기 [Article Type] Review